Catherine Sohn, Director at Jazz Pharmaceuticals, holds 0.00 shares in Maze Therapeutics, Inc. (Ticker: MAZE), holds 1.00K shares in Altimmune (Ticker: ALT), holds 14.87K shares in Jazz Pharmaceuticals (Ticker: JAZZ).
Catherine Sohn latest transaction was an Uninformative Buy of $306.48K.
What was Catherine Sohn's most profitable transaction?
Catherine Sohn’s most profitable transaction was an Informative Buy of LFCR stock on June 10, 2014. The return on the trade was 26.90%.
What is Catherine Sohn's role in Jazz Pharmaceuticals?
Catherine Sohn's role in Jazz Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.